Advocacy Summit on Capitol Hill
Your voice matters. As oncologists, you are uniquely qualified to communicate with Congress about effective policies for the treatment of patients with cancer and the research that drives scientific
Related Articles
“Bluesky Has the Juice”: Celebrities Flee “Toxic” X for Rival Social Media Site
Actors, directors, musicians and journalists are among the millions that have joined up to Bluesky since the presidential election.
Internal Medicine Physicians Stress the Importance of Vaccines and Evidence-Based Public Health Policies | ACP Online
Statement attributable to: Isaac O. Opole, MBChB, PhD, MACPPresident, American College of Physicians
Doctors migrating to bluesky is like Harris declining to speak with Joe Rogan
Far left ideology is to be afraid of open dialog
Help me Challenge Cancer!
The DCC is a year-round collective community movement to raise money in support of Sylvester Comprehensive Cancer Center at the University of Miami. With your…
FDA Approves Revumenib in KMT2A-Rearranged Acute Leukemia
Revumenib is now an FDA-approved treatment for adult and pediatric patients with relapsed/refractory KMT2A-rearranged acute leukemia.
Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Stereotactic body radiotherapy (SBRT) has firmly established its role in stage I non-small cell lung cancer (NSCLC). Clinical trial results may not fully apply to…
‘Bobby is an outlier’: Inside RFK Jr’s mad world of crackpots, cranks and vaccine conspiracies
The next US health secretary has suggested erecting a statue of the disgraced British doctor who claimed the MMR vaccine causes autism
TO PASS S. 1828, AMENDING THE PUBLIC HEALTH SERVICE ACT … — Senate Vote #118 — Jul 7, 1971
Senate Vote #118 in 1971, in the United States Congress.
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
AbstractBackground and Aims. Standardized definitions for outcome measures in randomized clinical trials and observational studies are essential for robust
